Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) 74% HIGHER; today provided an update on the status of its New Drug Application for Silenor (doxepin) for the treatment of insomnia. Click here for the full report.
Conexant Systems Inc. (NASDAQ: CNXT) 13.7% HIGHER; reports Q1 EPS of $0.17, 6 cents better than the analyst estimate of $0.11.
Revenue for the quarter was $61.8 million, which compares to the estimate of $60.10 million. Conexant expects revenues for the second quarter of fiscal 2010...
Post new comment